SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

25 May 2022 Evaluate
The sales for the March 2022 quarter moved down to Rs. 636.73 millions as compared to Rs. 694.79 millions during the year-ago period.Net Profit recorded in the quarter ended March 2022 rise to 43.18% to Rs. 66.48  millions  compared to R. 46.43 millions in corresponding previous quarter.OP of the company witnessed a marginal growth to 109.86 millions from 88.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 636.73 694.79 -8.36 2196.26 2654.57 -17.26 2196.26 2654.57 -17.26
Other Income 57.72 59.21 -2.52 276.43 199.66 38.45 276.43 199.66 38.45
PBIDT 109.86 88.00 24.84 268.93 552.56 -51.33 268.93 552.56 -51.33
Interest 6.08 2.50 143.20 16.10 26.80 -39.93 16.10 26.80 -39.93
PBDT 103.78 86.37 20.16 252.83 500.15 -49.45 252.83 500.15 -49.45
Depreciation 23.41 26.07 -10.20 95.93 91.28 5.09 95.93 91.28 5.09
PBT 80.37 60.30 33.28 156.90 408.87 -61.63 156.90 408.87 -61.63
TAX 13.89 13.87 0.14 8.91 87.74 -89.84 8.91 87.74 -89.84
Deferred Tax 3.04 5.67 -46.38 5.20 26.89 -80.66 5.20 26.89 -80.66
PAT 66.48 46.43 43.18 147.99 321.13 -53.92 147.99 321.13 -53.92
Equity 496.74 496.74 0.00 496.74 496.74 0.00 496.74 496.74 0.00
PBIDTM(%) 17.25 12.67 36.22 12.24 20.82 -41.17 12.24 20.82 -41.17

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×